Home › Borstkanker › Californië › Mountain View
Borstkanker klinische studies in Mountain View, CA
26 studies voor Borstkanker zoeken deelnemers op locaties in en rond Mountain View (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruterenFase 3
- Stanford Women's Cancer Center, Palo Alto · 5 mijl verwijderd
A Study of PHST001 in Advanced Solid Tumors
RekruterenFase 1
- Stanford University School of Medicine, Palo Alto · 5 mijl verwijderd
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruterenFase 3
- El Camino Hospital, Mountain View
- Palo Alto Medical Foundation, Mountain View
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
RekruterenFase 1/2
- Stanford Medicine Cancer Center, Stanford · 5 mijl verwijderd
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruterenFase 3
- El Camino Hospital Cancer Center ( Site 0096), Mountain View
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruterenFase 1
- Stanford University Medical Center, Stanford · 5 mijl verwijderd
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruterenFase 1
- Stanford University Medical Center, Stanford · 5 mijl verwijderd
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- Stanford Cancer Center, Palo Alto · 5 mijl verwijderd
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruterenFase 3
- Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto · 5 mijl verwijderd
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Stanford Women's Cancer Center, Palo Alto · 5 mijl verwijderd
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
RekruterenFase 1
- Stanford University Hospital, Stanford · 5 mijl verwijderd
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RekruterenFase 3
- Research Site, Palo Alto · 5 mijl verwijderd
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
RekruterenFase 2
- Stanford Cancer Institute, Palo Alto · 5 mijl verwijderd
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruterenFase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mijl verwijderd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mijl verwijderd
- en nog 1
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
RekruterenFase 2
- Stanford University, Stanford · 5 mijl verwijderd
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekruterenFase 2/3
- Local Institution - 0358, Stanford · 5 mijl verwijderd
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruterenFase 3
- Stanford Medicine Cancer Center - Stanford Women's Cancer Center, Palo Alto · 5 mijl verwijderd
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RekruterenFase 1
- Stanford University Medical Center, Palo Alto · 5 mijl verwijderd
Magnetic Resonance Imaging of Breast Cancer
RekruterenGezonde vrijwilligers welkom
- Stanford University School of Medicine, Stanford · 5 mijl verwijderd
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
RekruterenObservatieonderzoek
- Stanford University School of Medicine, Stanford · 5 mijl verwijderd
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mijl verwijderd
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mijl verwijderd
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RekruterenFase 1
- Stanford Cancer Institute, Stanford · 5 mijl verwijderd
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Rekruteren
- Stanford University, Stanford · 5 mijl verwijderd
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruterenObservatieonderzoek
- Stanford Cancer Institute, Palo Alto · 5 mijl verwijderd
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Stanford · 5 mijl verwijderd
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Mountain View
- Kanker (alle vormen)40 studies
- Metastatische kanker25 studies
- Niet-kleincellige longkanker21 studies
- Acute myeloïde leukemie19 studies
- Eierstokkanker19 studies
- Autismespectrumstoornis17 studies
- Longkanker17 studies
- Prostaatkanker15 studies
- Hartfalen15 studies
- Autisme13 studies
- Acute lymfoblastaire leukemie13 studies
- Colorectale kanker13 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.